Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease
PubMed, Sun, Siyu, et al
One impact of the plant (main constituents are harmine and harmaline ) is that it increases GLP-1 in the hippocampus.[ref] Lithium: Lithium carbonate seems to suppress food intake (in some people) by activating GLP-1
Today, these drugs are helping millions of people gain better control over their blood sugar, lose weight, and reduce cardiovascular and other health risks
Many people find that food becomes less emotionally and sensory appealing during treatment, not because they are unhappy, but because the biological signals that previously drove food-seeking behaviour have changed
Tracking macros teaches you invaluable information about how to properly fuel your body, while GLP-1s help make it easier to eat in alignment with your body's needs
